European Journal of Organic Chemistry
10.1002/ejoc.201800908
FULL PAPER
1
616, 1587, 1429, 1421, 1394, 1273, 1235, 1199, 1154, 1092, 966, 883,
c) X. Yang, Q. Shi, C.-Y. Lai, C.-Y. Chen, E. Ohkoshi, S.-C. Yang, C.-Y.
Wang, K. F. Bastow, T.-S. Wu, S.-L. Pan, C.-M. Teng, P.-C. Yang, K.-
H. Lee, J. Med. Chem. 2012, 55, 6751–6761; d) M. S. Christodoulou, F.
Calogero, M. Baumann, A. N. García-Argáez, S. Pieraccini, M. Sironi,
F. Dapiaggi, R. Bucci, G. Broggini, S. Gazzola, S. Liekens, A. Silvani,
M. Lahtela-Kakkonen, N. Martinet, A. Nonell-Canals, E. Santamaría-
Navarro, I. R. Baxendale, L. Dalla Via, D. Passarella, Eur. J. Med.
Chem. 2015, 92, 766−775; e) F. Liéby-Muller, F. Marion, P. Schmitt, J.-
P. Annereau, A. Kruczynski, N. Guilbaud, C. Bailly, Bioorg. Med. Chem.
Lett. 2015, 25, 184–187; f) Y. Kwon, J. Song, H. Lee, E.-Y. Kim, K. Lee,
S. K. Lee, S. Kim, J. Med. Chem. 2015, 58, 7749−7762; g) Y. Liu, L.
Qing, C. Meng, J. Shi, Y. Yang, Z. Wang, G. Han, Y. Wang, J. Ding, L.-
H Meng, Q. Wang, J. Med. Chem. 2017, 60, 2764−2779.
1
846, 769, 714, 661, 636, 552, 545, 519, 475, 435. H NMR (600 MHz,
DMSO-d
6
) δ 9.79 (s, 1H, OH), 8.45 (d, J = 8.2 Hz, 1H), 8.28 (s, 1H), 8.19
(
(
(
d, J = 8.3 Hz, 1H), 8.12 (t, J = 7.5 Hz, 1H), 7.91 (t, J = 7.5 Hz, 1H), 3.09
t, J = 7.5 Hz, 2H), 2.33 (t, J = 7.3 Hz, 2H), 2.08 – 1.99 (m, 2H). C NMR
151 MHz, DMSO-d
13
6
) δ 173.91, 147.63, 146.27, 138.48, 135.84, 129.95,
129.63, 126.87, 125.91, 122.83, 32.71, 31.90, 24.03. HRMS: (ESI)
+
Calculated for C13
H
3
13NO (231.25) [M+Na] : 254.0788, found 254.0791.
Isomerization of 21 to pyridone 11 in hydrochloric acid solution.
Using the procedure as described for the synthesis of 22 from 2,3-
dihydro-1H-pyrido[1,2-b]isoquinolin-4(6H)-one (21) (190 mg, 1 mmol) in a
3
7% HCl (15 mL) at 120 °C for 10 h. The yellow oil obtained after cooling
and concentration of dichloromethane was purified by silica gel column
chromatography (20 x 600 mm, 100 g SiO , eluent: CH Cl /MeOH, 50:1)
the procedure provided pale yellow crystals of dienone 11 in 82% yield
161 mg). The physicochemical and spectral data of both compounds
[
6]
a) T. F. Buckley, H. Rapoport, J. Org. Chem. 1983, 48, 4222−4232; (b)
Guan, S. Chen, Z. Liu J. Org. Chem. 2011, 76, 5363–5368.
2
2
2
–
(
[
[
7]
8]
X. Tian, X. Chen, L. Gan, J. C. Hayes, A. G. Switzer, M. G. Solinsky, F.
H. Ebetino, J. A. Wos, B. B. Pinney, J. A. Farmer, D. Crossdoersen, R.
J. Sheldon, Bioorg. Med. Chem. Lett. 2006, 16, 1721−1725.
obtained are in full agreement with the derivative prepared by reaction of
ketone 9 with PPA as described above.
a) B. Rigo and N. Kolocouris, J. Heterocycl. Chem., 1983, 20, 893−898;
b) B. Rigo, P. Gautret, A. Legrand, S. El Ghammarti, D. Couturier,
Synth. Commun. 1994, 24, 2609−2615; c) S. Al Akoum Ebrik, A.
Legrand, B. Rigo, D. Couturier, J. Heterocycl. Chem. 1999, 36,
Acknowledgements
9
97−1000; d) A. Legrand, B. Rigo, P. Gautret, J.–P. Hénichart, D.
This work was supported by the Grant Agency of the Slovak
Republic (No. 1/0371/16). The authors gratefully acknowledge
the Research Centre for Industrial Synthesis of Drugs, ITMS
Couturier, J. Heterocycl. Chem. 1999, 36, 1263−1270; e) A. Legrand,
B. Rigo, J.–P. Hénichart, B. Norberg, F. Camus, F. Durant, D.
Couturier, J. Heterocycl. Chem. 2000, 37, 215−227; f) R. Akué-Gédu,
S. Al Akoum Ebrik, A. Witczak-Legrand, D. Fasseur, S. El Ghammarti,
D. Couturier, B. Decroix, M. Othman, M. Debacker, B. Rigo,
Tetrahedron 2002, 58, 9239–9247; g) K. Kadlečíková, V. Dalla, Š.
Marchalín, B. Decroix, P. Baran, Tetrahedron 2005, 61, 4743–4754.
a) Š. Marchalín, B. Decroix, J. Morel, Acta Chem. Scand. 1993, 47,
26240220061, supported by the Research & Development
Operational Program funded by the ERDF. This contribution is
also made by technical help of “Fondation de La Catho de Lille”,
the French School of High Studies in Engineering (HEI), and the
University of Le Havre Normandie for technical and financial
aids. The crystal structure determinations were made with the
support of the project "University Science Park of STU
Bratislava", ITMS 26240220084, supported by the Research &
Development Operational Program funded by the ERDF.
[
9]
287–291; b) Š. Marchalin, B. Decroix, J. Heterocycl. Chem. 1994, 31,
495−499; c) A. Daïch, B. Decroix, J. Heterocycl. Chem. 1996, 33,
873−878; d) N. Szemes, Š. Marchalín, F. Bar, B. Decroix, J. Heterocycl.
Chem. 1998, 35, 1371–1375; e) Š. Marchalín, F. Szemes, N. Bar, B.
Decroix, Heterocycles 1999, 50, 445–452; f) P. Šafář, J. Žúžiová, M.
Bobošikova, Š. Marchalín, N. Prónayová, S. Comesse, A. Daïch,
Tetrahedron: Asymmetry 2009, 20, 2137–2144; g) P. Šafář, J. Žúžiová,
Š. Marchalín, E. Tothova, N. Prónayová, Ĺ. Švorc, V. Vrábel, A. Daïch,
Tetrahedron: Asymmetry 2009, 20, 626–634; h) R. Akué-Gédu, D.
Couturier, J.-P. Hénichart, B. Rigo, G. Sanz, L.Van Hijfte, A. Bourry,
Tetrahedron 2012, 68, 1117–1127.
Keywords: Amino acids • (S)-Aminoadipic acid • -Cationic
Cyclization • N-Acyliminium Species • Isoquinolines • Lactams •
Nitrogen heterocycles • Pyridoisoquinolines
[
[
[
1]
2]
3]
P. Clinton, O. Wyman, M. Mozeson, The Pharm. Exec. 50.
Pharmaceutical Executive 2010, pp. 69-80.
[10] For recent example of FTase inhibitors from the group, see: I.-M.
Moise, A. Ghinet, D. Belei, J. Dubois, A. Farce, El. Bîcu, Bioorg. Med.
Chem. Lett. 2016, 26, 3730–3734.
For interesting review on this area, see: J. P. Michael, Nat. Prod. Rep.
2008, 25, 139-165.
[11] For recent example of tubulin polymerization inhibitors, see: a) C.-M.
Abuhaie, E. Bîcu, B. Rigo, P. Gautret, D. Belei, A. Farce, J. Dubois, A.
Ghinet, Bioorg. Med. Chem. Lett. 2013, 23, 147-152; b) A. Ghinet, P.
Gautret, N. Van Hijfte, B. Ledé, J.-P. Hénichart, E.Bîcu, U. Darbost, B.
Rigo, A. Daïch, Chem. Eur. J. 2014, 20, 10117–10130.
a) H. Hamamoto, Y. Shiozaki, H. Nambu, K. Hata, H. Tohma, Y. Kita,
Chem. - Eur. J. 2004, 10, 4977−4982; b) W. Zeng, S. R. Chemler, J.
Org. Chem. 2008, 73, 6045−6047; c) A. McIver, D. D. Young, A.
Deiters, Chem. Commun. 2008, 4750−4752; d) A. Stoye, T. Opatz, Org.
Lett. 2010, 12, 2140−2141; e) T. N. Barrett, D. C. Braddock, A. Monta,
M. R. Webb, A. J. P. White, J. Nat. Prod. 2011, 74, 1980−1984; f) Z.
Wang, A. Feng, M. Cui, Y. Liu, L. Wang, Q. Wang, PLoS One 2012, 7,
e52933-e52933; g) A. A. van Loon, M. K. Holton, C. R. Downey, T. M.
White, C. E. Rolph, S. R. Bruening, G. Li, K. M. Delaney, S. J. Pelkey,
E. T. Pelkey, J. Org. Chem. 2014, 79, 8049−8058.
[12] a) P. Šafář, J. Žúžiová, E. Tothova, Š. Marchalín, N. Prónayová, Ĺ.
Švorc, V. Vrábel, S. Comesse, A. Daïch, Tetrahedron: Asymmetry
2010, 21, 623−630; b) P. Šafář, J. Žúžiová, Š. Marchalín, N. Prónayová,
Ĺ. Švorc, V. Vrábel, S. Šesták, D. Rendić, V. Tognetti, L. Joubert, A.
Daïch, Eur. J. Org. Chem. 2012, 5498−5514.
[13] V. G. Granik, Russ. Chem. Rev. 1982, 51, 119–134.
[14] N. O. Brace, J. Org. Chem. 1995, 60, 2059–2071.
[
[
4]
5]
C. Anton-Torrecillas, I. Bosque, J.C. Gonzalez-Gomez, M. Isabel Loza,
J. Brea, J. Org. Chem. 2015, 80, 1284−1290.
[15] A. K. Bonetskaya, N. F. Erofeeva, S. M. Skuratov, Azv. Vyssh. Uchebn.
Zaved., Khim. Khim. Tekhnol. 1960, 1027–1030; Chem. Abstr. 1961, 55,
87095.
a) For significant biological activities of phenanthroquinolizidines, see:
X. Yang, Q. Shi, S.-C. Yang, C.-Y. Chen, S.-L. Yu, K. F. Bastow, S. L.
Morris-Natschke, P.-C. Wu, C.-Y. Lai, T.-S. Wu, S.-L. Pan, C.-M. Teng,
J.-C. Lin, P.-C. Yang, K.-H. Lee, J. Med. Chem. 2011, 54, 5097-5107;
b) M. W. Leighty, G. I. Georg, ACS Med. Chem. Lett. 2011, 2, 313–315;
[16] T. H. Lane, C. L. Fry, J. Org. Chem. 1978, 43, 4890–4891.
This article is protected by copyright. All rights reserved.